share_log

Cantor Fitzgerald Reiterates Overweight on Organogenesis Hldgs, Maintains $5 Price Target

Moomoo 24/7 ·  Mar 1 09:35

Cantor Fitzgerald analyst Ross Osborn reiterates Organogenesis Hldgs (NASDAQ:ORGO) with a Overweight and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment